Tag: ECST-2
CX 2026: Carotid trial debate highlights “key question” of cost-effectiveness
An audience poll asking, ‘What do we believe: ECST-2 or CREST-2?’ following a debate at the 2026 Charing Cross (CX) Symposium (21–23 April, London,...
Interim data find “no evidence of benefit” for carotid revascularisation additional...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
